Home/ Supplements/ Inositol/ Inositol Multivitamin

Inositol Multivitamin

product on market Capsule Peach Perfect Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 83% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Myo-inositol and D-chiro inositol are supported by moderate evidence for improving insulin sensitivity and hormonal balance. Omega-3, magnesium glycinate, and zinc contribute to metabolic and cognitive health, though evidence for this specific combination is limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Inositol Multivitamin
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
83%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

2000 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
200 mg (7% DV)
Within RDA (0.5× RDA)
10 mg (100% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)

Other Ingredients

Gelatin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Formulation Notes

Myo & D-Chiro Inositol Omega 3, Zinc, Vitamin D, Magnesium Inositol Multivitamin Myo-Inositol & D-Chiro Omega 3 Magnesium, Zinc, Vit. D3

Cycle regulation Fights imbalances Healthy skin & hair

100% made in Miami, FL 100% of batches 3rd party tested

No artificial ingredients

Additional Information

What's inside the capsules?

GMP Certified Good Manufacturing Practice GMP Certified Facility in USA

Metadata

Product Details

DSLD Entry Date2024-11-22
Product TypeOther Combinations
FormCapsule
DSLD ID325593
Data Updated2026-04-11
Research

Research Evidence

32
Research Sources
50
Avg Quality
19
Rct
7
Meta Analysis
3
Clinical Trial
2
Other
1
Systematic Review
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024 PubMed DOI
B Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Meta Analysis The Journal of clinical endocrinology and metabolism 2024 PubMed DOI
B Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
B Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis
Meta Analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022 PubMed DOI
B Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Meta Analysis Irish journal of medical science 2023 PubMed DOI
B Inositol for subfertile women with polycystic ovary syndrome
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
B Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives
Rct European review for medical and pharmacological sciences 2021 PubMed DOI
B The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Rct European review for medical and pharmacological sciences 2019 PubMed DOI
C Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis
Meta Analysis Expert review of endocrinology & metabolism 2024 PubMed DOI
C Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Rct International journal of food sciences and nutrition PubMed DOI
View all evidence for Inositol →
Compare

Similar Products

View all Inositol products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.